Clin2
NCT06320951Possibly a fitNot yet recruiting

A new medicine for heart and metabolic health in black adults

Cardiovascular DiseasesInsulin Sensitivity/ResistanceMetabolic DiseaseMetabolismEnergy ExpenditureObesity

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study tests whether a new medication can improve heart and metabolic health (like blood pressure and blood sugar control) in Black adults with obesity and high blood pressure. It aims to reduce risk of diabetes and heart disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You identify as Black or African American.
  • Your body mass index (BMI) is 30 or higher (obesity range).
  • You have insulin resistance (a lab test called HOMA-IR must be 2.5 or higher).
  • Your blood pressure is between 120-160 (top number) and 80-100 (bottom number), either untreated or after a short washout from up to two blood pressure medicines.
  • You are willing to follow the study plan and not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04055428Recruiting· Phase 2
Testing a hormone supplement to improve heart and metabolic health

This study tests whether adding a natriuretic peptide medicine improves heart health and metabolism in Black adults. It may help with blood pressure and related health markers, but you must meet specific health and safety criteria.

Birmingham, Alabama
NCT05216042Recruiting
Study of genetics and heart/metabolic health in adults

This study looks at how genetic markers (DNA) relate to heart health and “metabolic” health (how your body manages sugar and fat). You may be asked to provide genetic samples and follow study health checks and protocols to help researchers understand who is at higher risk.

Birmingham, Alabama
NCT07533175Recruiting· Phase 3
Testing a new weight-loss medicine for type 2 diabetes

This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.

Birmingham, Alabama
NCT07754474Recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT06818669Recruiting
Heart risk study for Black adults with food insecurity

This study tests if giving small rewards for buying healthy food and taking medicines can lower heart disease risk in African American adults who have trouble getting enough food. You will get help with food costs and health coaching.

Buffalo, New York
NCT07463196Recruiting· Phase 1
Study of ACI-19764 for healthy people and those with heart risks

This trial tests an experimental drug called ACI-19764 to see how safe it is, how the body handles it, and how it affects the immune system. It's for healthy adults and for adults with heart-related risk factors like obesity or type 2 diabetes.

Groningen

Hear when a new Cardiovascular Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.